These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 15501982

  • 21. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M, Wolf G.
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [Abstract] [Full Text] [Related]

  • 22. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS, Warburton P, O'Regan DJ, Ball SG, Turner NA, Porter KE.
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
    [Abstract] [Full Text] [Related]

  • 23. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARgamma in A549 cells.
    Kim HJ, Woo IS, Kang ES, Eun SY, Kim GH, Ham SA, Kim HJ, Lee JH, Chang KC, Kim JH, Lee HT, Seo HG.
    Biochem Biophys Res Commun; 2006 Oct 20; 349(2):660-7. PubMed ID: 16945329
    [Abstract] [Full Text] [Related]

  • 24. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages.
    Ringseis R, Schulz N, Saal D, Eder K.
    J Nutr Biochem; 2008 Sep 20; 19(9):594-603. PubMed ID: 18155510
    [Abstract] [Full Text] [Related]

  • 25. Troglitazone inhibits cell migration, adhesion, and spreading by modulating cytoskeletal rearrangement in human breast cancer cells.
    Wang PS, Chou FS, Porchia L, Saji M, Pinzone JJ.
    Mol Carcinog; 2008 Dec 20; 47(12):905-15. PubMed ID: 18314876
    [Abstract] [Full Text] [Related]

  • 26. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S.
    Mol Pharmacol; 2008 Oct 20; 74(4):952-63. PubMed ID: 18599600
    [Abstract] [Full Text] [Related]

  • 27. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
    Yang CC, Wang YC, Wei S, Lin LF, Chen CS, Lee CC, Lin CC, Chen CS.
    Cancer Res; 2007 Apr 01; 67(7):3229-38. PubMed ID: 17409431
    [Abstract] [Full Text] [Related]

  • 28. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells.
    Lovekamp-Swan T, Chaffin CL.
    Mol Cell Endocrinol; 2005 Apr 15; 233(1-2):15-24. PubMed ID: 15767042
    [Abstract] [Full Text] [Related]

  • 29. Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment.
    Narayanan PK, Hart T, Elcock F, Zhang C, Hahn L, McFarland D, Schwartz L, Morgan DG, Bugelski P.
    Cytometry A; 2003 Mar 15; 52(1):28-35. PubMed ID: 12596249
    [Abstract] [Full Text] [Related]

  • 30. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR, Choi HN, Lee HJ, Baek HA, Park HS, Jang KY, Chung MJ, Moon WS.
    Oncol Rep; 2007 Oct 15; 18(4):825-32. PubMed ID: 17786342
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells.
    Motomura W, Nagamine M, Tanno S, Sawamukai M, Takahashi N, Kohgo Y, Okumura T.
    J Gastroenterol; 2004 Oct 15; 39(5):461-8. PubMed ID: 15175945
    [Abstract] [Full Text] [Related]

  • 32. Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture.
    Fröhlich E, Machicao F, Wahl R.
    Endocr Relat Cancer; 2005 Jun 15; 12(2):291-303. PubMed ID: 15947104
    [Abstract] [Full Text] [Related]

  • 33. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M, Wang J, Chen P, Reilly RM.
    Bioconjug Chem; 2006 Jun 15; 17(5):1280-7. PubMed ID: 16984139
    [Abstract] [Full Text] [Related]

  • 34. Pivotal role of peroxisome proliferator-activated receptor gamma (PPARgamma) in regulation of erythroid progenitor cell proliferation and differentiation.
    Nagasawa E, Abe Y, Nishimura J, Yanase T, Nawata H, Muta K.
    Exp Hematol; 2005 Aug 15; 33(8):857-64. PubMed ID: 16038777
    [Abstract] [Full Text] [Related]

  • 35. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T, Hayashi S, Miki Y, Nakamura Y, Moriya T, Sugawara A, Ishida T, Ohuchi N, Sasano H.
    Endocr Relat Cancer; 2006 Mar 15; 13(1):233-50. PubMed ID: 16601291
    [Abstract] [Full Text] [Related]

  • 36. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice.
    Lu J, Imamura K, Nomura S, Mafune K, Nakajima A, Kadowaki T, Kubota N, Terauchi Y, Ishii G, Ochiai A, Esumi H, Kaminishi M.
    Cancer Res; 2005 Jun 01; 65(11):4769-74. PubMed ID: 15930296
    [Abstract] [Full Text] [Related]

  • 37. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
    Weng JR, Chen CY, Pinzone JJ, Ringel MD, Chen CS.
    Endocr Relat Cancer; 2006 Jun 01; 13(2):401-13. PubMed ID: 16728570
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC.
    Clin Cancer Res; 2008 Jul 01; 14(13):4045-52. PubMed ID: 18593980
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.